Med-Design/BD Corp.
This article was originally published in The Gray Sheet
Executive Summary
Med-Design finalizes licensure of 11 infusion therapy, blood collection and syringe safety-engineered devices to BD Corp. in exchange for $4 mil. up front and additional royalty payments, Med-Design announces May 16. Of the $4 mil., $1.5 mil. has been recognized in the first quarter and $2.5 mil. in the second quarter. Med-Design anticipates receiving royalties on the BD products starting this year